Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Teenagers Archives
Print | Email | Share | Comments (1)

Study Suggests Extended Release Metformin May Reduce Body Mass Index in Teens


Feb 10, 2010

The findings could point the way to the use of Metformin in treating adolescent obesity, a condition that sharply increases teens’ potential for developing type 2 diabetes.

A California study that tracked 77 obese adolescents for almost two years indicates that metformin XR, an extended-release version of the popular anti-diabetic drug, may help lower body mass index in overweight teens who do not have diabetes.

The change in BMI, although not dramatic, was statistically significant. The findings could point the way to the use of metformin in treating adolescent obesity, a condition that sharply increases teens' potential for developing type 2 diabetes.

The study was undertaken by researchers at Stanford University and the Lucile S. Packard Children's Hospital in California and by members of the Glaser Pediatric Research Network Obesity Study Group, a clinical research network. Conducting a lifestyle intervention program that stressed increased physical activity and careful diet, the researchers assigned daily 2,000 mg doses of metformin XR to 39 obese adolescents and a placebo to 38 others for 48 weeks. The teens were ages 13 to 18. The scientists found that after 52 weeks, the patients on metformin XR had an average 0.9 decrease in their BMI. The patients on the placebo had an average BMI increase of 0.2.

The effects of the treatment, which the researchers tracked an additional 48 weeks after discontinuing the drugs, lasted up to 24 weeks before the BMI differences in the two patient groups began narrowing.

The researchers, who published their results in the February 2010 issue of Archives of Pediatrics and Adolescent Medicine, concluded that although their study sample was too small to issue a definitive opinion about metformin XR as a treatment for obesity, it opens the door to larger studies involving the drug. One advantage, they pointed out, was that the patients tolerated metformin XR well-a finding that accords with researchers' and doctors' experiences with the drug over the years.

* * *

Source:

Medication May Help Decrease BMI in Obese Adolescents

http://www.sciencedaily.com/releases/2010/02/100201171529.htm 


Categories: Adolescent Boys, Adolescent Girls, Diabetes, Diabetes, Metformin, Pre-Diabetes, Teenagers, Type 2 Issues



You May Also Be Interested In...


Comments

Posted by Anonymous on 14 February 2010

This Metrofin i had to come off it due to stomach problems constant and i am on at present something new on the market sitagliptin Januvia and it seems to be working and have not felt any dizziness on taking it tablet form as well as the glickerzide i am informed not many on this tablet sitagliptin and the chemist i have to order itwell before running out.


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.